Shedding light on the FDA's 510(k) approvals process: low-level laser therapy devices used in the treatment of androgenetic alopecia

2018 ◽  
Vol 30 (5) ◽  
pp. 489-491 ◽  
Author(s):  
Sophie Wang ◽  
Divya Seth ◽  
Harib Ezaldein ◽  
Raghav Tripathi ◽  
Miesha Merati ◽  
...  
Keyword(s):  
Laser Therapy ◽  
Androgenetic Alopecia ◽  
Low Level Laser Therapy ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser

Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia

2020 ◽  
Vol 35 (6) ◽  
pp. 1239-1244 ◽  
Author(s):  
Hassan Galadari ◽  
Swathi Shivakumar ◽  
Torello Lotti ◽  
Uwe Wollina ◽  
Andy Goren ◽  
...  
Keyword(s):  
Laser Therapy ◽  
Narrative Review ◽  
Androgenetic Alopecia ◽  
Low Level Laser Therapy ◽  
Treatment Modalities ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser

Low-level laser therapy as a treatment for androgenetic alopecia

2016 ◽  
Vol 49 (1) ◽  
pp. 27-39 ◽  
Author(s):  
Ladan Afifi ◽  
Eric L. Maranda ◽  
Mina Zarei ◽  
Gina M. Delcanto ◽  
Leyre Falto-Aizpurua ◽  
...  
Keyword(s):  
Laser Therapy ◽  
Androgenetic Alopecia ◽  
Low Level Laser Therapy ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser

Assessment of healing of dental implant surgical site following Low-Level Laser Therapy using Bio-Clinical parameters: An Exploratory Study

2020 ◽  
Author(s):  
VARSHA PALLED ◽  
DR. JITENDRA RAO ◽  
DR. RAGHUWAR DAYAL SINGH ◽  
DR. SHUCHI TRIPATHI ◽  
DR. KALPANA SINGH ◽  
...  
Keyword(s):  
Laser Therapy ◽  
Test Group ◽  
Low Level Laser Therapy ◽  
Control Group ◽  
Clinical Parameters ◽  
Implant Stability ◽  
Low Level ◽  
Implant Stability Quotient ◽  
Low Level Laser ◽  
Level Laser

The purpose of this study was to evaluate whether Low-Level Laser Therapy (LLLT) improves the healing of the implant surgical site with clinical and biochemical parameters.Thirty patients with an edentulous space spanning a single tooth were selected. The patients were randomly allocated to two groups - the control group and the test group. The test group received laser energy at a power of 2J/cm 2 with a total of 4-6J energy over each implant. Clinical parameters (Implant Stability Quotient, probing index, modified sulcus bleeding index)and osteoprotegerin (OPG) were assessed at baseline and follow-up intervals (2 weeks, 6 weeks, and 3 months).The test group showed significantly higher implant stability quotient compared to thecontrol group at 2 weeks(57.93±3.95 and 35.67±3.08; p<0.01) and 3months(58.86±3.75 and 67.06±3.78; p<0.01). A significant rise in OPG levels of the test group(686.30±125.36pg/ml at baseline and 784.25±108.30pg/ml at 3months;p<0.01) was seen contrary to significant decline in the control group (839.50±249.08pg/ml at baseline,415.30±78.39pg/ml at 3months;p<0.01). Within the limitations of the study, the study suggests that the healing of peri-implant hard and soft tissues may be enhanced with the use of LLLT as an explicit modality during the post-operative period.

Low-level laser therapy for neurosensory recovery after sagittal ramus osteotomy

2020 ◽  
Vol 69 (3) ◽  
Author(s):  
Paulo Esteves Pinto Faria ◽  
Astrid Temprano ◽  
Fábio Piva ◽  
Eduardo Sant'ana ◽  
Dênis Pimenta
Keyword(s):  
Laser Therapy ◽  
Low Level Laser Therapy ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser
Sign in / Sign up

Export Citation Format

Share Document